Background {#Sec1}
==========

The diagnostic value of saliva has been focused due to the advantages of its simple and non-invasive collection procedures. For salivary diagnostics, whole saliva rather than glandular saliva has been usually used, and whole saliva is a mixture of exocrine secretions of the salivary glands, microbes, mucosal exudates, gingival crevicular fluid, and desquamated oral epithelial cells. Therefore, the diagnostic value of whole saliva may be compromised when blood contamination, originating either from the loss of mucosal integrity or from gingival exudates, is present. Because the analyte levels are much higher in blood compared to those in saliva, when blood leakage reaches a certain level, the salivary concentrations of analytes are abnormally elevated \[[@CR1], [@CR2]\].

Several methods have been proposed to determine blood contamination levels in whole saliva. The first method is to detect a blood tint in a saliva sample by the naked eye \[[@CR3]\]. Second, strips for urinalysis have been used \[[@CR4]\]. Both methods have relatively low levels of sensitivity \[[@CR1]\], and the second method has a possibility of false-positive \[[@CR5]\]. The other methods involve measuring the salivary levels of plasma proteins such as hemoglobin \[[@CR6]\], albumin \[[@CR7]\], and transferrin \[[@CR1], [@CR2], [@CR8]\]. Among these methods, measuring the transferrin levels in saliva samples has been regarded as the most reliable method for detecting the level of blood contamination in saliva. However, recent research findings have suggested that this method may also have drawbacks in clinical and research applications \[[@CR9]--[@CR13]\]. Thus, the aim of study was to investigate whether salivary transferrin level could be a proper marker for the level of blood contamination in whole saliva samples.

Methods {#Sec2}
=======

Participants {#Sec3}
------------

To investigate the factors that could influence salivary levels of transferrin, we re-analyzed the data from our two previous papers \[[@CR10], [@CR14]\]. One study explored changes in salivary hormones throughout the menstrual cycle in 30 younger healthy females (mean age: 25.9 ± 2.1 years) \[[@CR10]\]. The other investigated salivary cytokine levels in patients with a specific oral mucosal pain condition \[[@CR14]\]. This study included 20 healthy age-matched females as a control group (mean age: 65.1 ± 9.0 years). We re-analyzed the data from the 30 younger women from the first study and the 20 older women (the control group) from the second study. For younger females, the data obtained in their follicular phases, when oral examinations including measuring the gingival index were conducted, were used in the present study.

Clinical evaluation {#Sec4}
-------------------

In both studies, the subjects received oral examinations and were confirmed to have intact oral mucosal integrity and no oral mucosal diseases. The extent of gingival inflammation was evaluated by the total gingival index, a modified version of Löe's gingival index, which reflects sum of gingival inflammation of all remained teeth. To obtain the total gingival index, four gingival areas (facial, mesial, distal, and lingual) adjacent to each tooth were assessed and were given a score from 0 to 3. The scores from the four areas of each tooth were totaled and divided by four to give an average score for each tooth. By adding the average scores from all teeth, the total gingival index for each individual was obtained.

Collection of whole saliva samples {#Sec5}
----------------------------------

In both studies, the same methods were used to collect saliva samples. Saliva samples were collected in the morning to reduce circadian variations in salivary compositions. Participants were instructed to abstain from eating and drinking for about two hours prior to the collection of samples. Unstimulated whole saliva (UWS) was collected for 10 min by the spitting method. Stimulated whole saliva (SWS) was collected for 5 min with the chewing of 1 g of gum base. The flow rates were expressed as mL/min.

Determination of blood contamination in saliva samples {#Sec6}
------------------------------------------------------

In both studies, the transferrin levels in saliva samples were determined by the enzyme immunoassay method using the same commercial kits (Salimetrics, State College, PA, USA). Secretion rates of transferrin were calculated by multiplying the salivary flow rates and their corresponding concentrations of transferrin.

Statistics {#Sec7}
----------

Based on the Kolmogorov-Smirnov normality test, the data were normally distributed; therefore, parametric tests were applied. The Student's t-test and Pearson's correlation analysis with Bonferroni's correction were used. *P*-values less than 0.05 were considered statistically significant.

Results {#Sec8}
=======

Age, oral conditions, salivary flow rate, and concentration and secretion rate of transferrin {#Sec9}
---------------------------------------------------------------------------------------------

The total gingival indices which reflect the degree of overall gingival inflammation were significantly lower (*P* \<  0.001) and the tooth number was significantly higher (*P* = 0.003) in the younger females than in the older ones. However, transferrin concentrations were higher in the younger females than in the older ones, although there was no statistically significant difference. Because of their higher salivary flow rates, the secretion rates of transferrin were significantly higher in the younger females in both UWS (*P* \<  0.001) and SWS (*P* \< 0.001) (Table [1](#Tab1){ref-type="table"}).Table 1Age, oral conditions, salivary flow rate, and concentration and secretion rate of transferrin in younger and older female subjectsYounger (*n* = 30)Older (*n* = 20)*P* valueAge (years)25.9 ± 2.165.1 ± 9.0\< 0.001^\*\*^Tooth number28.0 ± 2.024.9 ± 6.00.003^\*\*^Total gingival index17.7 ± 16.023.2 ± 10.6\< 0.001^\*\*^Flow rate (mL/min)UWS0.46 ± 0.270.20 ± 0.160.078SWS1.54 ± 0.480.83 ± 0.430.556Concentration of transferrin (mg/dL)UWS1.16 ± 0.960.65 ± 0.820.357SWS0.49 ± 0.380.29 ± 0.300.227Secretion rate of transferrin (μg/min)UWS4.18 ± 2.870.90 ± 0.84\< 0.001^\*\*^SWS6.62 ± 4.441.62 ± 0.90\< 0.001^\*\*^UWS, unstimulated whole saliva; SWS, stimulated whole salivaTotal gingival index reflects the degree of overall gingival inflammation in the oral cavitySecretion rates of transferrin were calculated by multiplying the flow rates of saliva and their corresponding concentrations of transferrinThe results in the table are from our two previous studies. The data from younger females were adapted from Lee et al. \[[@CR10]\] and those from older females were adapted from Suh et al. \[[@CR14]\]^*\*\**^*P* \< 0.01 by the Student's t-test

Correlations among total gingival index, salivary flow rate, and concentration and secretion rate of transferrin in UWS and SWS {#Sec10}
-------------------------------------------------------------------------------------------------------------------------------

The total gingival index had no significant positive correlation with either the concentration or secretion rate of transferrin in both UWS and SWS of younger and older female subjects (Table [2](#Tab2){ref-type="table"}). However, the correlation coefficient was 0.462 (*P* = 0.010) between the total gingival index and the concentration of transferrin in the SWS from the younger females (Table [2](#Tab2){ref-type="table"}). The salivary concentration of transferrin showed negative correlations with the flow rate of saliva in both the younger and older groups, but significant differences were found only in SWS in both younger (*r* = − 0.506, *P* = 0.004) and older (*r* = − 0.644, *P* = 0.004) participants. There were significant positive correlations between the salivary concentrations and secretion rates of transferrin for both UWS and SWS of younger and older groups (*P* \< 0.001) (Table [2](#Tab2){ref-type="table"}).Table 2Correlations among total gingival index, salivary flow rate, and concentrations and secretion rates of transferrin in UWS and SWS in younger and older femalesFlow rateConcentration of transferrinSecretion rate of transferrinFlow rateConcentration of transferrinSecretion rate of transferrinIn UWS of younger femalesIn SWS of younger females Total gingival index−0.2460.109−0.122− 0.3410.4620.325 Flow rate−0.4550.119−0.506^\*^−0.110 Concentration of transferrin0.666^\*\*^0.879^\*\*^In UWS of older femalesIn SWS of older females Total gingival index0.0040.1090.2830.2090.0590.041 Flow rate−0.3520.062−0.644^\*^−0.360 Concentration of transferrin0.847^\*\*^0.809^\*\*^UWS, unstimulated whole saliva; SWS, stimulated whole salivaTotal gingival index reflects the degree of overall gingival inflammation in the oral cavitySecretion rates of transferrin were calculated by multiplying the flow rates of saliva and their corresponding concentrations of transferrinThe results in the table are from our previous studies \[[@CR10], [@CR14]\]^\*^*P* \< 0.0083, ^*\*\**^*P* \< 0.0017 by the Pearson's correlation analysis with Bonferroni's correction

Discussion {#Sec11}
==========

From the results of the present study, several factors which could influence the level of transferrin in whole saliva could be derived. Because the subjects had intact mucosal integrity, gingival inflammation might be the only source of blood contamination in saliva samples. The total gingival indices were lower in the younger females than in the older ones, but transferrin concentrations were higher in the younger females than in the older ones. There are two possible reasons for these results. Primarily, younger individuals may exhibit better transferrin synthesis compared to older ones. One previous report mentioned an age-related decrease in salivary transferrin levels \[[@CR13]\], which supports our results. Second, the levels of gonadal hormones and the state of menopause might affect the synthesis of transferrin, an iron-containing protein. In the proliferative phase such as the follicular and ovulatory phases, the level of transferrin in blood needs to be elevated to cope with the increased demand of the active metabolism of proliferating endometrial cells \[[@CR12]\]. Thus, post-menopausal women showed decreased transferrin levels in blood compared to pre-menopausal women \[[@CR9]\]. Interestingly, our previous study showed that the salivary concentration of transferrin during the ovulatory phase was higher than those during other phases, although there were no statistically significant differences \[[@CR10]\]. Therefore, the influences of age and gonadal hormones could explain the higher concentrations and secretion rates of salivary transferrin in the younger females compared to the older ones despite the lesser degree of gingival inflammation in the younger subjects. Additionally, one animal study proposed endogenous transferrin synthesis in parotid acinar cells and active transportation of transferrin to parotid acinar cells after its synthesis in hepatic cells \[[@CR11]\], suggesting that transferrin in whole saliva may not be solely a product of blood.

We found that the concentrations of transferrin in UWS were higher than those in SWS. The salivary concentrations of transferrin also had negative correlations with the flow rates of saliva. These results indicate that salivary flow rate affects the level of transferrin in saliva and that dilution effects occur in the stimulated condition.

The total gingival index showed no positive correlation with transferrin concentration in either UWS or SWS, but the correlation coefficient between the total gingival index and the concentration of transferrin was close to the statistical significant level only in the SWS of the younger females. The younger females may have had better chewing performance during the collection of SWS, because the younger females had more teeth than the older ones and usually younger adults had a greater biting force than older ones. Therefore, the possibility of the leakage of gingival exudates into saliva during chewing could be higher in the younger females as compared to the older ones. Tooth mobility during chewing could give rise to increased blood vessel transudation, which could be related to increases in exudates from the gingival crevice, and could ultimately increase the level of blood contamination in saliva \[[@CR15]\].

Conclusions {#Sec12}
===========

Diagnostic studies using saliva usually include quantitative analyses of whole saliva samples, and the reliability and validity of salivary data are affected by the level of blood contamination in these saliva samples. When using the salivary level of transferrin as a blood contamination marker, the influences of age, gonadal hormones, salivary flow rate, and chewing performance need to be considered. Further studies are also needed to identify better markers for detecting blood contamination in saliva samples.
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